Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Monday 09 May 2022 8:15 am  |  Updated:  Monday 09 May 2022 8:16 am

Londoner rushed to St Thomas hospital and put in isolation after catching extremely rare Monkeypox virus

By: Michiel Willems

Add as a preferred source on Google
The patient is currently in isolation at St Thomas' Hospital

UKHSA has confirmed to City PM that a Londoner has been diagnosed with monkeypox.

“The patient has a recent travel history from Nigeria, which is where they are believed to have contracted the infection, before travelling to the UK,” the agency wrote in an email.

“The patient is receiving care at the expert infectious disease unit at the Guy’s and St Thomas’ NHS Foundation Trust, London.”

Dr Nicholas Price, Director NHSE High Consequence Infection Diseases (airborne) Network and Consultant in Infectious Diseases at Guy’s and St Thomas’ said that “the patient is being treated in our specialist isolation unit at St Thomas’ Hospital by expert clinical staff with strict infection prevention procedures.” 

Extremely rare

Monkeypox is a rare viral infection that does not spread easily between people. It is usually a mild self-limiting illness and most people recover within a few weeks. However, severe illness can occur in some individuals.

Initial symptoms of monkeypox include fever, headache, muscle aches, backache, swollen lymph nodes, chills and exhaustion. A rash can develop, often beginning on the face, then spreading to other parts of the body. The rash changes and goes through different stages before finally forming a scab, which later falls off.

The infection can be spread when someone is in close contact with an infected person, however, there is a very low risk of transmission to the general population.

Read more

Harley Street Health District Releases First Annual Impact Report

“As a precautionary measure, UKHSA experts are working closely with NHS colleagues and will be contacting people who might have been in close contact with the individual to provide information and health advice,” the agency said.

This includes contacting a number of passengers who travelled in close proximity to the patient on the same flight to the UK.

People without symptoms are not considered infectious but, as a precaution, those who have been in close proximity are being contacted to ensure that if they do become unwell they can be treated quickly.

If passengers are not contacted then there is no action they should take, UKHSA said.

“It is important to emphasise that monkeypox does not spread easily betwee people and the overall risk to the general public is very low,” said Dr Colin Brown, Director of Clinical and Emerging Infections, UKHSA.

“We are working with NHS EI to contact the individuals who have had close contact with the case prior to confirmation of their infection, to assess them as necessary and provide advice.

“UKHSA and the NHS have well established and robust infection control procedures for dealing with cases of imported infectious disease and these will be strictly followed.”

Read more

cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • air travel
  • business travel
  • London

Trending Articles

  • Burnham tax plans spark investor rush to bank capital gains

  • Nothing fails to file accounts months after dissolution threat

  • I’ve taken the best train trips in the world. Here are my 5 favourites

  • Cruyff turn: Starmer allows pubs to stay open for England World Cup game

  • Nottingham Forest owner Marinakis announces £210m stadium plans

More from City PM

  • Harley Street Health District Releases First Annual Impact Report

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Overture Life Launches Global ICSI.A Center of Excellence Program, Bringing the World’s First Automated ICSI into Clinical Use Across Five Leading Global Fertility Centers

    Business Wire
  • IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

    Business Wire
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • Oxford St vs the Square Mile: a tale of two cities

    Opinion
    Bustling Oxford Street with shoppers and iconic red buses on a vibrant day, capturing the essence of Londons famous shoppi...

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy